{"sector":{"0":"Healthcare"},"longName":{"0":"Ipca Laboratories Limited"},"fullTimeEmployees":{"0":15155},"longBusinessSummary":{"0":"Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic\/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, dermatology, diabetology, gastroenterology, haematology, neurology, ophthalmology, rheumatology, and urology, as well as respiratory, psychiatry, probiotics, orthopedics, oral anti diabetes drug, nutraceuticals, NSAIDs, neuropathic pain, malaria, infectious diseases, immunosuppressant, hepatoprotectives, helminthics, fever, and emollients\/protectives. It exports its products to approximately 100 countries worldwide. The company was incorporated in 1949 and is based in Mumbai, India."},"city":{"0":"Mumbai"},"phone":{"0":"91 22 6210 5000"},"website":{"0":"https:\/\/www.ipca.com"},"grossProfits":{"0":36225200000},"totalCash":{"0":13602199552},"totalDebt":{"0":8072200192},"totalRevenue":{"0":58504499200},"totalCashPerShare":{"0":53.614},"revenuePerShare":{"0":230.6},"bookValue":{"0":345.163},"priceToBook":{"0":2.442614},"marketCap":{"0":106969153536},"averageVolume":{"0":259424},"fiftyTwoWeekHigh":{"0":1128.5},"fiftyTwoWeekLow":{"0":831.05},"logo_url":{"0":"https:\/\/logo.clearbit.com\/ipca.com"}}